Bronchiectasis in severe α 1 -antitrypsin deficiency: lessons for the pulmonologist

Read full text
Authors: Christine J. Kang, Pamela J. McShane
Cited by: 0
References: 11

Abstract

Extract Recent scientific investigation has reshaped the pathophysiological paradigm of bronchiectasis, shifting the focus from chronic infection to chronic inflammation. Central to this inflammatory process is aberrant neutrophil behaviour, particularly the dysregulated activity of neutrophil-derived proteases. Given this mechanistic insight, one might expect deficiency of α1-antitrypsin (α1-AT), a key endogenous protease inhibitor, to be well characterised in this context. However, the relationship between α1-AT deficiency (α1-ATD) and bronchiectasis remains poorly defined.

Fields of Study & Subjects

Cystic Fibrosis Research Advances Chronic Obstructive Pulmonary Disease (COPD) Research Protease and Inhibitor Mechanisms

Publication details

Journal / source
ERJ Open Research
Volume
12
Issue
1
Pages
01473–2025
Publication date
1 January 2026
Language
EN